Skip to main content
10x Genomics, Inc. logo

10x Genomics, Inc. — Investor Relations & Filings

Ticker · TXG ISIN · US88025U1097 LEI · 5493003Z6741WNLG7H43 US Manufacturing
Filings indexed 637 across all filing types
Latest filing 2026-06-08 Declaration of Voting R…
Country US United States of America
Listing US TXG

About 10x Genomics, Inc.

https://www.10xgenomics.com/

10x Genomics, Inc. is a life science technology company that develops and manufactures integrated solutions for biological research. Its systems, which include instruments, consumables, and software, enable scientists to analyze biological systems at high resolution and scale. The company's core product platforms are Chromium for high-throughput single-cell analysis with multiomic capabilities, Visium for spatial whole transcriptome analysis within morphological context, and Xenium for subcellular in situ spatial imaging of RNA and protein. These technologies empower researchers to dissect cellular heterogeneity, map spatial gene expression patterns, and decipher cellular interactions within tissues. The platforms are widely used across diverse fields, including oncology, immunology, and neuroscience, to accelerate biological discovery and advance human health.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is an SEC Form 8-K, specifically Item 5.07 “Submission of Matters to a Vote of Security Holders,” detailing the proposals voted on at the 2026 Annual Meeting and the exact voting tallies (for, against, abstentions, broker non-votes). This matches the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-06-08 English
8-K - 10x Genomics, Inc. (0001770787) (Filer)
Earnings Release Classification · 94% confidence The document is a Form 8-K current report filed under Item 2.02 “Results of Operations and Financial Condition,” attaching a press release announcing the company’s quarterly financial results. It does not contain full financial statements itself but provides the initial earnings press release. This matches the definition of an Earnings Release (ER). Q1 2026
2026-05-07 English
DEF 14A - 10x Genomics, Inc. (0001770787) (Filer)
Proxy Solicitation & Information Statement
2026-04-24 English
4 - 10x Genomics, Inc. (0001770787) (Issuer)
Director's Dealing
2026-03-25 English
SCHEDULE 13G/A - 10x Genomics, Inc. (0001770787) (Subject)
Major Shareholding Notification
2026-03-25 English
4 - 10X GENOMICS, INC. (0001770787) (Filer)
Director's Dealing
2026-03-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.